首页 | 本学科首页   官方微博 | 高级检索  
     

HDA方案治疗急性非淋巴细胞白血病临床研究
引用本文:赵秀兰,殷晓华,陈方,李丹红,张晓敏. HDA方案治疗急性非淋巴细胞白血病临床研究[J]. 白血病.淋巴瘤, 1994, 0(3)
作者姓名:赵秀兰  殷晓华  陈方  李丹红  张晓敏
作者单位:牡丹江医学院血液病研究所
摘    要:1985年~1993年收治急性非淋巴细胞白血病(ANLL)218例,用HDA方案治疗72例,CR率为76.38%、HA方案治疗78例,CR率44.87%、DA方案治疗68例,CR率48.85%,HDA组与HA、DA组疗效差异显著(P<0.005),CR后必须坚持长期多疗程的强化治疗才能延长生存期、提高治愈率。

关 键 词:急性非淋巴细胞白血病(ANLL),完全缓解(CR)

CLINICAL STUDY ON THE TREATMENT OF ACUTE NONLYMPHOBLASTIC LEUKEMIA WITH HDA REGIMEN
zhao XiulaN,et al Institute of Hematology,Mudan jiang Medical College. CLINICAL STUDY ON THE TREATMENT OF ACUTE NONLYMPHOBLASTIC LEUKEMIA WITH HDA REGIMEN[J]. Journal of Leukemia & Lymphoma, 1994, 0(3)
Authors:zhao XiulaN  et al Institute of Hematology  Mudan jiang Medical College
Abstract:18 cases of acute on lymphoblastic leukemia(ANLL)were treated with HDA,HA and DA regimens from 1985 to 1993. The CR rates in HDA group(72cases),HA group(78cases)and DAgroup(68cases)were 76.38%,44.87%and 48.85%respectively. The CR rate in HDA group wassignificantly higher than that in HA and DA groups(P<0.005).After CR,continuous,multiple andintensive treatment were needed to prolong the life-spans of the patients and improve the CR rate.
Keywords:ANLL CR
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号